MKC-1

· CASI Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MKC-1, covering 2009-05-05 to 2012-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer [Phase 2]